13F Pro Quality Score

56.4/100

Rank #1,102 of 2,879 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

87.6/100

Profitability

47.4/100

Balance Sheet

58.2/100

Earnings Quality

82.7/100

Free Cash Flow

37.1/100

Institutional Flow

15.1/100

Revenue Scale

48.3/100

Dilution Risk

58.4/100

PNTG Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Pennant Group, Inc. (PNTG), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PNTG at 56.4/100 on a 32-signal composite quality model, placing it at rank #1,102 of 2,879 stocks — the top half of the AI-ranked universe. PNTG scores in the top quartile across revenue growth (87.6), earnings quality (82.7). Areas of concern include institutional flow (15.1) and free cash flow (37.1), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), Pennant Group, Inc. reports quarterly revenue of $285.4M, net income of $8.5M, an operating margin of 6.1%. Top institutional holders of PNTG by reported 13-F value include BlackRock,, Turtle Creek Asset Management, WASATCH ADVISORS, based on the most recent SEC filings. PNTG trades on the Nasdaq exchange and files with the SEC under CIK 1766400. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PNTG daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Pennant Group, Inc. directly from SEC EDGAR. Pennant Group, Inc.'s 13F Pro composite quality score has ranged between 8 and 70 since 2021, currently 56.4 — a stable long-term trajectory across 56 quarterly and live scoring snapshots.

Fun facts about Pennant Group, Inc.

Quirks, history, and lore behind PNTG — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    A U.S. healthcare services company · small-cap · listed on Nasdaq · headquartered in Idaho.
  • 2
    The Numbers
    Annual revenue in the range of roughly $500 million, spread across hundreds of care locations in more than a dozen states — growth driven largely by acquisitions.
  • 3
    The History
    Spun off in 2019 from a larger home-health parent, it immediately began building its own portfolio of senior-care businesses as an independent public company.
  • 4
    The Secret
    It runs a decentralized operating model — local leaders own the culture — which its founders argue produces better outcomes than the corporate-campus-knows-best approach.
  • 5
    The Lore
    The company sits in Eagle, Idaho — not exactly a healthcare hub — yet it manages a sprawling network of home health, hospice, and senior living communities from the high desert.
  • 6
    The Giveaway
    Its name evokes a flag flying over a care campus, its ticker is PNTG, and it is laser-focused on senior and post-acute care across the American West and beyond.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$285.4M

Net Income

Q1 2026

$8.5M

Free Cash Flow

Q1 2026

$-8.7M

Operating Margin

Q1 2026

6.1%

ROIC

Q1 2026

3.1%

D/E Ratio

Q1 2026

0.44

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+36.3% YoY
$947.7MFY 2025
FY21 $439.7MFY22 $473.2MFY24 $695.2MFY25 $947.7M

Net Income

+31.1% YoY
$29.6MFY 2025
FY21 $2.7MFY22 $6.6MFY24 $22.6MFY25 $29.6M

Operating Income

+36.1% YoY
$51.9MFY 2025
FY21 $4.7MFY22 $12.7MFY24 $38.1MFY25 $51.9M

EPS (Diluted)

+20.0% YoY
$0.84FY 2025
FY21 $0.09FY22 $0.22FY24 $0.70FY25 $0.84

Total Assets

+42.5% YoY
$968.2MFY 2025
FY21 $530.3MFY22 $512.1MFY24 $679.5MFY25 $968.2M

Total Debt

$173.8MFY 2025
FY21 $51.4MFY22 $62.9MFY24 $0.00FY25 $173.8M

Op. Cash Flow

+22.9% YoY
$48.3MFY 2025
FY21 $-18.2MFY22 $9.0MFY24 $39.3MFY25 $48.3M

AI Insight: PNTG Ratio Trends

PNTG's operating margin recovered to 6.1% in Q1 2026 after a Q3 2025 trough, but profitability remains range-bound with no clear expansion trend.

Operating margin dipped to 4.5% in Q3 2025 before recovering to 6.0% in Q4 2025 and 6.1% in Q1 2026, suggesting seasonal softness rather than structural deterioration.

Net profit margin has stayed in a narrow 2.7%–3.7% band across all reported quarters, indicating limited earnings leverage on revenue.

ROA declined from 4.2% in Q1 2025 to 3.2% in Q3 2025, recovering modestly to 3.6% in Q1 2026 — still below the prior-year peak.

ROIC swung from 96.4% in Q1 2025 to 40.8% in Q1 2026 and is missing for three quarters — data gaps obscure capital efficiency trends.

Q3 2025 saw the weakest margins across all metrics; whether that seasonal pattern repeats in Q3 2026 is a key inflection to monitor.

Get alerted when PNTG's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Pennant Group, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of PNTG

Put PNTG on your watchlist

Track score changes the day Pennant Group, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is PNTG a good stock to buy?

13F Pro's AI-powered analysis of Pennant Group, Inc. (PNTG) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for PNTG are available on the PNTG stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own PNTG?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling PNTG. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Pennant Group, Inc.'s investment landscape.